Nabi repurchases $18.7 million in 2.875% convertible senior notes

By Devika Patel

Knoxville, Tenn., March 11 - Nabi Biopharmaceuticals said it bought back $18.7 million of its 2.875% convertible senior notes for $16.6 million in the fourth quarter, for a $1.6 million gain.

Nabi repurchased a total of $57.3 million of the notes for $51.6 million during 2008, leaving a balance of $16.3 million as of Dec. 27.

Nabi is a Boca Raton, Fla.-based biotechnology firm.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.